A community oncology pharmacist explains how seeing patients across the course of their diagnosis builds trust and why accessibility remains the field’s biggest challenge despite advances in AI.
|Videos|July 3, 2013
The Use of Specialty Tiers
Debbie Stern of Rxperts discusses the findings from the EMD Serono Specialty Digest, 9th Edition, and the use of specialty drug tiers by payers.
Advertisement
Debbie Stern of Rxperts discusses the findings from the EMD Serono Specialty Digest, 9th Edition, and the use of specialty drug tiers by payers. Video taken at the 2013 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.
For more on this topic and a full review of the report, see:
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
2
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
3
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
4
The Most Accessible Healthcare Professional—But Accessible to Whom?
5